Pediatric kidney disease requires early diagnosis and specialized care to support growth, development, and long-term health.
Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the kidneys. Over time, the ...
Clinical Data doubles known genetic factors associated with urate and GoutCALGARY, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) -- ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor ...
SonoThera™, a biotechnology company dedicated to treating the root cause of human diseases by developing the next generation ...
Early detection of kidney disease is crucial for effective treatment, emphasizes KIMS Hospitals' leaders during a health awareness cyclothon.
Xortx Therapeutics announces pioneering research on genome-wide pathogenic pathways in gout: Calgary, Alberta Saturday, January 3, 2026, 13:00 Hrs [IST] Xortx Therapeutics Inc., a ...
The Alpestria-1 study enrolled (in France, USA and Spain) 26 patients with Alport syndrome at high risk of a rapid loss of kidney function despite stable multiple SoC drugs, including ...
TipRanks on MSN
XORTX highlights new gout genetics research, reshapes board and clarifies financing as Vectus deal nears closing
The latest announcement is out from XORTX Therapeutics Inc ( ($TSE:XRTX) ). On December 31, 2025, XORTX Therapeutics highlighted newly published, ...
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused ...
The U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) updated their 2019 clinical practice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback